Skip to main content
. Author manuscript; available in PMC: 2011 Aug 15.
Published in final edited form as: Clin Cancer Res. 2010 Aug 3;16(16):4126–4134. doi: 10.1158/1078-0432.CCR-10-0168

Table 4.

Correlation between dysplasia and SMAD4 immunostaining in juvenile polyps.

Normal SMAD4 IHC Reduced/lost SMAD4 IHC Total
No dysplasia 5 (56%) 4 (44%) 9
Indefinite for dysplasia 2 (50%) 2 (50%) 4
Dysplasia (LGD and HGD) 6 (66%) 3 (33%) 9